Study on Androgen Receptor and Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female|Triple Negative and Androgen Receptor Positive
Interventions: DRUG: Darolutamide|DRUG: Capecitabine
Sponsor: UNICANCER